trihexyphenidyl has been researched along with Bradyarrhythmia in 2 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blumensohn, R | 1 |
| Razoni, G | 1 |
| Shalev, A | 1 |
| Munitz, H | 1 |
| Madill, HD | 1 |
| Stewart, WC | 1 |
| Savoie, ML | 1 |
2 other studies available for trihexyphenidyl and Bradyarrhythmia
| Article | Year |
|---|---|
Bradycardia due to trihexyphenidyl hydrochloride.
Topics: Adult; Bradycardia; Humans; Male; Trihexyphenidyl | 1986 |
Central and peripheral anticholinergic potency of some drugs antagonistic to anticholinesterase poisoning.
Topics: Animals; Antidotes; Atropine; Bradycardia; Carbachol; Central Nervous System; Cholinesterase Inhibit | 1968 |